IE

Imran Eba

Partner at Action Potential Venture Capital

Cambridge, Massachusetts

Overview 

Imran Eba is a Partner at Action Potential Venture Capital in Cambridge, Massachusetts, with a strong background in investment management, finance, and business development. He has served on the boards of multiple companies and has made significant investments in the biotech sector, including leading Series A funding for Alpheus Medical. Eba's career highlights include his current role as a Partner at Action Potential Venture Capital and his past experience as a Director at GlaxoSmithKline, where he held various key positions in investment management and business development.

Work Experience 

AP

Action Potential Venture Capital

  • Partner

    2013 - Current

    www.actionpotentialvc.com

M

MicroTransponder

  • Board Member

    2022

MicroTransponder is a medical device company that develops and commercializes neurostimulation devices to treat neurological diseases.

Raised $115,120,987.00 from MedTech Innovator.

microtransponder.com
AM

Alpheus Medical, Inc

  • Board Member

    2020

Alpheus Medical provides a novel sonodynamic therapy platform targeting solid body cancers.

Raised $30,000,000.00 from BrightEdge Fund, Action Potential Venture Capital, Medtech Convergence Fund, SV Health Investors, OrbiMed, Action Potential Venture Capital, BrightEdge Fund, SV Health Investors, OrbiMed and National Brain Tumor Society.

alpheusmedical.com
NM

Neuspera Medical Inc.

  • Board Member

    2016

NeuSpera Medical is a manufacturing firm that designs, manufactures, and sells implantable neuromodulation medical devices.

Raised $134,888,888.00 from Action Potential Venture Capital, Treo Ventures, Windham Venture Partners, Vertex Ventures HC and Olympus.

neuspera.com
AT

Axon Therapies Inc.

  • Board Member

    2014

Axon Therapies develops a healthcare device with a neuromodulation approach to treat heart failure.

Raised $3,299,999.00 from Deerfield and Action Potential Venture Capital.

axontherapies.com
SM

SetPoint Medical

  • Board Member

    2013

SetPoint Medical develops novel therapeutics for the treatment of chronic autoimmune conditions.

Raised $344,000,000.00 from Citta Capital, SVE Capital, Shangbay Capital, Gilmartin Capital LLC, New Enterprise Associates, Boston Scientific, Action Potential Venture Capital, Richard King Mellon Foundation and Euclidean Capital.

setpointmedical.com
HI

Hartford International

  • Trustee and Member of the Investment and Finance Committees

    2019

CD

Creative Destruction Lab

  • Mentor

    2021

HH

Harvard HealthTech

  • Progam Advisor

    2019

G

GlaxoSmithKline

  • Director, Investment Management, Worldwide Business Development

    2011 - 2013

    Led establishment of an investment management practice within GSK with a remit of managing the company’s investments in external technology and innovation. Responsible for (1) identifying, evaluating, structuring, executing and monitoring GSK’s investments in life science venture capital funds as limited partners, (2) managing GSK’s direct investments in biotechs made as part of R&D collaborations, and (3) establishing spinouts based around GSK technologies.

  • Director, Transactions, Worldwide Business Development

    2009 - 2011

  • Manager, Deal Finance and M&A, Worldwide Business Development

    2008 - 2009

  • Senior Business Risk Consultant

    2005 - 2007

Education 

Investments 

Alpheus Medical

Series A

Total funding: $30M

Articles About Imran

Relevant Websites